KRISTI ACKER: Open Payments
NPI 1730413691 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 36 payments from 17 companies in 2025. Trend: 2023 $689 · 2024 $586 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $112 |
| BeOne Medicines USA, Inc. | 5 | $95 |
| E.R. Squibb & Sons, L.L.C. | 4 | $69 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Astellas Pharma US Inc | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $64 |
| Merck Sharp & Dohme LLC | 2 | $54 |
| Daiichi Sankyo Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Incyte Corporation | 2 | $35 |
Products named: AUSTEDO XR, Xtandi, BRUKINSA, OPDIVO, KEYTRUDA, IMFINZI, Enhertu, SCEMBLIX.
Industry payments across AL — which companies pay providers there.
